This is an in depth discussion about the connection between flame retardants and plastics, and thyroid cancer. These chemicals, also known as endocrine disruptors, have a clear connection to thyroid cancer occurrence. The research is presented by Julie Ann Sosa, MD MA FACS is Chief of Endocrine Surgery at Duke University and leader of the endocrine neoplasia diseases group in the Duke Cancer Institute and the Duke Clinical Research Institute. She is Professor of Surgery and Medicine. Her clinical interest is in endocrine surgery, with a focus in thyroid cancer.
60% of people in the U.S. have thyroid nodules, and almost all are benign — the others maybe reason for concern. M. Regina Castro, MDis a consultant in the Division…
Dr. Bridget Brady is Austin's first fellowship-trained endocrine surgeon. In this episode the following topics are discussed: Austin Thyroid Surgeons sees 30 patients per week with thyroid nodules Up to 80% of US population could have a thyroid nodule(s) less than 5% of Dr Brady's thyroid nodule patients test positive for cancer How relevant is what I don’t know won’t hurt me in thyroid cancer and biopsies of nodules? BETHESDA system or the middle category, also known as indeterminate For thyroid nodules that are indeterminate, historically a surgery would be performed With molecular testing, surgery can be decreased by up to 50% Afirma molecular testing uses messenger RNA If Afirma comes back suspicious it does NOT necessarily mean it is cancer
Dr. Hernán Tala es endocrinólogo de la Clinica Alemana en Santiago, Chile. Su area especialidad incluye cáncer de tiroides avanzado, endocrinologia general, y enfermedades tiroides. Los temas presentados incluyen: * Una mejor comprensión de la biología del cáncer de tiroides, y que no todo el cáncer de tiroides es igual. La enfermedad es única en cada paciente. * La importancia de entender el perfil del cáncer en cada paciente. * Diagnóstico del nódulo. * Perfil molecular del nódulo tiroideo. * Una pausa en la exploración universal del cáncer de tiroides. * Vigilancia activa
A different approach to treating thyroid cancer compared to the U.S. Dr. Takahiro Okamoto helped write the Japanese guidelines on thyroid cancer. He is Professor & Chair of the Department of Surgery at Tokyo Women's Medical University. Key points from this episode include: * Most Western countries carry out total thyroidectomies, whereas in Japan, the approach is more conservative with a fundamental practice of hemithyroidectomy whenever possible. * By not doing a total thyroidectomy, this allows the patient to not avoid taking thyroid replacement medication. * Complete thyroidectomy is conducted when 80-90% of lymph nodes have metastasis. * I-131 treatment is decreasing despite cases of cancer increasing * For I-131 treatment, patients wait more than 6 months post surgery. * When receving I-131 treatment, patients be admitted to hospital for several days. * TSH suppression therapy is common in Western countries, whereas in Japan, measures are taken to avoid TSH suppression by not removing all of the thyroid. * Normal TSH in Japan is 4.3 or less.
Cáncer de Tiroides, con la Dra Ines Califano de Universidad de Buenos Aires Reduzca la ansiedad durante el tratamiento del cáncer de tiroides En esta entrevista, discutimos lo siguiente: 1. ¿Qué es un nódulo? 2. ¿Qué sucede durante ecografia? 3. ¿Qué sucede durante la oja fina? 4. Si es cáncer, ¿siempre hace la cirugía? 5. Si no es cáncer, ¿algunas veces hace cirugía?
Undesired consequences and a patient’s profession should weigh heavily in the decision to have thyroid surgery, or not. Dr. Allen Hois a fellowship-trained head and neck surgeon who focuses on…
The past year has been fascinating and highly fruitful year for Dartmouth Institute Associate Professor Louise Davies, MD, MS. A 2017-2018 Fulbright Global Scholar, Davis spent several months in Japan…
Scheduled to publish next month, the statistics show thyroid surgery much less safe than thought. The findings that 12% of patients overall had thyroid surgery specific complications is concerning, but more concerning is surgeons quote a 1 to 3 percent rate of error. In the case of surgery for metastatic thyroid cancer, the error rate skyrockets to 23%. Dr. Maria Papaleontiou is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes.
If you select carefully, the unwanted errors of thyroid surgery can be avoided. Dr. Ralph P. Tufano is the Director of the Division of Head and Neck Endocrine Surgery at The Johns Hopkins School of Medicine, and conducts thyroid and parathyroid surgery with a focus on optimizing outcomes. In this interview, items discussed include: * the emotional burden of being diagnosed with cancer and the haste that sometimes follows * the unnecessary damage of thyroid surgery, including the cutting of the laryngeal nerve resulting in vocal cord paralysis, low calcium levels and a need to supplement calcium and Vitamin D for life, and leaving residual disease behind * knowing your risk factor and finding the right medical team to address it